Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says

 
• By Brenda Sandburg
  
Creative pathway
Creative approach is needed for approval of rare disease treatments • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Conferences